Botanix Pharmaceuticals Ltd
ASX:BOT

Watchlist Manager
Botanix Pharmaceuticals Ltd Logo
Botanix Pharmaceuticals Ltd
ASX:BOT
Watchlist
Price: 0.395 AUD 2.6% Market Closed
Market Cap: 723.9m AUD

Intrinsic Value

The intrinsic value of one BOT stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.395 AUD, Botanix Pharmaceuticals Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

BOT Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Botanix Pharmaceuticals Ltd

BOT
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BOT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

A delay or failure in Botanix’s clinical trials for its leading synthetic cannabinoid therapies would significantly undermine investor confidence, given that the company’s core revenue potential relies on successful product approvals for conditions like acne and dermatitis.

Bull Theses

Botanix’s proprietary Permetrex technology, designed to enhance the skin penetration of its synthetic cannabinoid formulations, provides a potential competitive advantage in drug delivery and differentiation from other dermatology players.

Show More Less
How do you feel about BOT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Botanix Pharmaceuticals Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Botanix Pharmaceuticals Ltd

Current Assets 67.8m
Cash & Short-Term Investments 48.4m
Receivables 799.5k
Other Current Assets 18.6m
Non-Current Assets 31.7m
PP&E 925.7k
Intangibles 30.7m
Efficiency

Free Cash Flow Analysis
Botanix Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Botanix Pharmaceuticals Ltd

Revenue
569.6k AUD
Cost of Revenue
-1.3m AUD
Gross Profit
-724.9k AUD
Operating Expenses
-39.7m AUD
Operating Income
-40.4m AUD
Other Expenses
1.1m AUD
Net Income
-39.3m AUD
Fundamental Scores

BOT Profitability Score
Profitability Due Diligence

Botanix Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROIC is Increasing
Positive 1-Year Revenue Growth
hidden
Profitability
Score

Botanix Pharmaceuticals Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BOT Solvency Score
Solvency Due Diligence

Botanix Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Botanix Pharmaceuticals Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BOT Price Targets Summary
Botanix Pharmaceuticals Ltd

Wall Street analysts forecast BOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BOT is 0.663 AUD with a low forecast of 0.657 AUD and a high forecast of 0.683 AUD.

Lowest
Price Target
0.657 AUD
66% Upside
Average
Price Target
0.663 AUD
68% Upside
Highest
Price Target
0.683 AUD
73% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BOT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Ownership

BOT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one BOT stock?

The intrinsic value of one BOT stock under the Base Case scenario is hidden AUD.

Is BOT stock undervalued or overvalued?

Compared to the current market price of 0.395 AUD, Botanix Pharmaceuticals Ltd is hidden .

Back to Top